All stocks / AIBT
AIBOTICS THERAPIES, INC. AIBT
Aibotics Therapies (AIBT): shares outstanding up 343% in a year, a late 10-Q notice in November 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- AIBOTICS INC
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 16
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $2,183
- Net loss
- ($2,215,751)
It spends more than it earns
Under strainCustomers paid it $2,183 in the year. It lost $2.2 million. For every $1 that came in, about $1016.00 went out.
- Cash and cash equivalents
- $255,940
- Net cash used in operating activities
- ($458,240)
The cash could run out soon
Under strainIt had $255,940 in the bank and used about $38,187 a month. At that pace the money lasts about 7 months unless it borrows or sells more shares.
- Total assets
- $874,673
- Total liabilities
- $4,834,905
It owes more than it owns
Under strainEverything the company owns adds up to $874,673. Its debts and unpaid bills add up to $4.8 million. That is about $5.53 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Filed NT 10-Q on 2026-11-16: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding rose from 191,904,437 (2025-08-19) to 850,165,334 (2026-08-19), up 343%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 850,165,334 shares as of 2026-08-19: 850,165,334 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Filed NT 10-Q on 2026-08-14: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-Q on 2026-05-15: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Filed NT 10-K on 2026-03-31: notice that a periodic report is late.
Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
| 2026-11-16 | NT 10-Q | FORM NT 10-Q FILING |
| 2026-10-29 | SCHEDULE 13G | |
| 2026-10-16 | 8-K | AIBOTICS, INC. - FORM 8-K SEC FILING |
| 2026-10-05 | 8-K | AIBOTICS, INC. - FORM 8-K SEC FILING |
| 2026-08-19 | 10-Q | AIBOTICS, INC. - FORM 10-Q SEC FILING |
| 2026-08-14 | NT 10-Q | FORM NT 10-Q FILING |
| 2026-06-09 | 10-Q | AIBOTICS, INC. - FORM 10-Q SEC FILING |
| 2026-05-15 | NT 10-Q | FORM NT 10-Q FILING |
| 2026-04-15 | 10-K | AIBOTICS, INC. - FORM 10-K SEC FILING |
| 2026-03-31 | NT 10-K | AIBOTICS, INC.- NT10K |
| 2026-01-28 | S-8 | AIBOTICS INC. - FORM S-8 FILING |
| 2025-11-19 | 10-Q | AIBOTICS, INC. - FORM 10-Q SEC FILING |
Common questions about AIBT
Does AIBT file reports with the SEC?
Yes. Aibotics Therapies files with the SEC under company number 0001763329. The most recent filing we hold is a NT 10-Q dated 2026-11-16.
Source recordHow many AIBT shares are outstanding?
850,165,334 shares as of 2026-08-19, as reported to the SEC. That is up 343% from 191,904,437 on 2025-08-19.
Source recordHas AIBT filed reports late?
Yes. In the last 12 months it filed 4 late-filing notices, most recently a NT 10-Q on 2026-11-16. A notice means a report was not ready on time; check whether the report followed.
Source recordIs Aibotics Therapies making money?
Customers paid it $2,183 in the year. It lost $2.2 million. For every $1 that came in, about $1016.00 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record